Van Diest Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Van Diest Capital's AMGN Position: Q2 2026 in Review
Van Diest Capital reduced its Amgen (AMGN) stake by 55% in Q2 2026, selling an estimated $315K and leaving 745 shares worth $270K. The position accounts for 0.24% of the portfolio, ranked #135.
Van Diest Capital first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $586K in Q1 2026. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Van Diest Capital held 745 shares of Amgen worth $270K as of Q2 2026.
- Van Diest Capital sold 919 Amgen shares in Q2 2026, an estimated $315K.
- Amgen made up 0.24% of Van Diest Capital's portfolio in Q2 2026, its #135 holding.
- Van Diest Capital first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
- Van Diest Capital's Amgen position peaked at $586K in Q1 2026.
- 3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Van Diest Capital's 13F filing for Q2 2026, filed 4 Aug 2026.